Contact Us
-
Building 2, QinChuang Chang'an Industrial Park,Chang'an District, Xi'an City, Shaanxi Province
-
+86-2988253271

98% Cycloastragenol Powder
Other name:Triterpene cycloxanol
English name: Cycloastragenol
Molecular formula: C30H50O5
Molecular weight: 490.71
CAS Number: 78574-94-4
Detection Method: HPLC≥98%
Properties: Colorless acicular crystal
MOQ:1KG
Storage method: 2-8°C, sealed away from light and stored in low temperature.
Certifications: Halal,ISO9001,PAHS Free,NON-GMO,KOSHER,SC
Precautions: This product should be stored in low temperature, exposure to the air for a long time, the content will be reduced.
Description
Brief introduction
Guanjie Biotech provides 98% Cycloastragenol Powder, which is from astragalus grown in our planting base. It is extracted, concentrated using a special process, and then processed into a powder using spray drying technology. The product exhibits good water solubility, instantly dissolving at room temperature, and maintains stable properties. It is readily and rapidly absorbed by the human body, making it suitable for use as raw material in pharmaceutical nutrition and veterinary feed production.

As a triterpenoid saponin, Cycloastragenol serves as the primary aglycone of Astragaloside and is mainly obtained through the hydrolysis of Astragaloside IV. In 2010, Geron Biotechnology Company of the United States discovered that cycloastragenol has a significant telomerase activation effect, thereby delaying telomere shortening and ultimately exhibiting anti-aging properties. Additionally, cycloastragenol also demonstrates potential pharmacological activities including antiviral effects, protection against lung injury, anti-depressive properties, and anti-hyperlipidemia effects.
Why Choose Guanjie?
● Innovative technology:
We are dedicated to the development of patented natural products with 3 patented technologies.
|
Patent No. |
Patent Name |
|
CN105755064A |
Abstract: The invention relates to a method for preparing phosphatidylserine by using liquid actinomycete GJ |
|
CN202122662941.X |
Abstract: The invention discloses a protective device for crushing structure |
|
CN216261052U |
Abstract: The invention discloses a high-efficiency crushing screening device, which comprises a feed hopper |
● International Certification System:
We have obtained ISO9001, ISO22000, IP (non-GMO), QS, Kosher, Halal, etc.
● Strict quality control system:
We conduct almost all product testing in-house, including assays, water content, odor, heavy metals, solvent residue, pesticide residue, protein content, microbiological tests, and more.
● Professional shipping:
Our professional shipping agents have cooperated with us for more than 15 years, ensuring that goods can be exported safely and quickly.
COA:
|
Item |
Specification |
Result |
Method |
|
Basic Product Information |
|||
|
Genus and Species |
Astragalus membranaceus (fisch)Bge |
Conform |
/ |
|
Part of the Plant |
Root |
Conform |
/ |
|
Country of Origin |
China |
Conform |
/ |
|
Marker Compounds |
|||
|
Cycloastragenol |
>98.0% |
99.85% |
HPLC |
|
Organoleptic Data |
|||
|
Appearance |
Powder |
Conform |
/ |
|
Color |
White fine powder |
Conform |
/ |
|
Odor |
Characteristic |
Conform |
/ |
|
Taste |
Characteristic |
Conform |
/ |
|
Melting point |
238℃-242℃ |
238℃-241℃ |
USP34 |
|
Physical Characteristics |
|||
|
Particle Size (80 mesh) |
98.0%pass 80mesh |
Conform |
GB/T 5507-2008 |
|
Loss on Drying |
<1.00% |
0.20% |
5g/105℃/2hrs |
|
Ash Content |
<1.00% |
0.08% |
2g/525℃/3hrs |
|
Heavy Metals |
|||
|
Total Heavy Metals |
<10 ppm |
Conform |
USP<231>, method II |
|
As |
<1.0 ppm |
Conform |
AOAC 986.15, 18th |
|
Pb |
<2.0 ppm |
Conform |
AOAC 986.15, 18th |
|
Hg |
<0.5 ppm |
Conform |
AOAC 971.21, 18th |
|
Cd |
<0.5 ppm |
Conform |
AOAC 971.21, 18th |
|
Pesticide Residue |
|||
|
666 |
<0.2ppm |
Conform |
GB/T5009.19-1996 |
|
DDT |
<0.2ppm |
Conform |
GB/T5009.19-1996 |
|
Microbiology |
|||
|
Total Plate Count |
<1,000cfu/g |
Conform |
AOAC 990.12, 18th |
|
Total Yeast & Mold |
<100cfu/g |
Conform |
FDA (BAM) Chapter 18, 8th Ed. |
|
E. Coli |
Negative |
Negative |
AOAC 997.11, 18th |
|
Salmonella |
Negative |
Negative |
FDA (BAM) Chapter 5, 8th Ed. |
Flow chart

Preparation Method
As an aglycone, the key to preparing 98% cycloastragenol powder is breaking the glycosidic bond. The cleavage of the aglylate bond can be achieved through homogeneous hydrolysis or two-phase hydrolysis. The latter method helps to avoid excessive contact of the aglylate with acids and bases, thus improving the yield of the acrylate. Depending on the catalyst used, the process can involve acid hydrolysis, alkali hydrolysis, acetylation, enzymatic hydrolysis, periodic acid lysis, and more. Current reports on the preparation of cycloastragenol mainly focus on acid hydrolysis, enzymatic hydrolysis, and periodic acid lysis.
Function:
● Anti~aging effect.
There are many theories about aging, but the telomere theory is the most influential. With deepening research on telomerase and telomeres, it is found that activation of telomerase can increase the number of cell divisions and prolong lifespan. Therefore, finding an effective telomerase activator is key to anti-aging. Bemanles et al. found that cycloastragalus alcohol can prolong shortened telomeres and increase the healthy lifespan of adult or elderly mice without increasing the incidence of diseases.
Cao Yanling et al. studied the anti-aging effect of cycloastragalus alcohol on d-galactose-induced aging mice, and the results showed significant anti-aging effects. This may be due to increased activity of total superoxide dismutase (T-SOD) and total antioxidant capacity (T-AOC), and decreased levels of malondialdehyde (MDA) and hydroxytrophin (HYP).
● Antiviral effect.
Cells of the immune system undergo a lot of division to perform their functions, resulting in low telomerase activity. Studies have shown that when immune activity T cells are stimulated, telomerase activity can be upregulated, and its intensity can be similar to that of tumor cells. Other studies have shown that decreased telomerase activity leads to premature decline in immune system function. Therefore, activating telomerase activity in T cells has become a focus of antiviral research. Molgora compared the effects of two astragalus extracts, TA-65 and HTA, on the proliferation and telomerase activity of human CD4 T cells and CD8 T cells. The results showed that TA-65, namely the alcohol extract of 98% Cycloastragenol Powder membranaceus, exhibited obvious telomerase activation. Fauce et al. have shown that telomerase enhancement is associated with enhanced T cell capacity and reduced HIV production. Therefore, TA-65 has the potential to treat other diseases that require enhanced telomerase activity in T cells.
● Protective effect of lung injury.
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic disease with an unclear cause, insidious onset, and aggravation, primarily affecting middle-aged people. In recent years, some scholars have found that IPF generation may be related to short telomeres, as the telomere length in patients' white blood cells is shorter than normal. Le Saux et al. studied the effect of cycloastragalus alcohol on bleomycin-induced fibrosis in mTERT heterozygous mice based on a mouse model of idiopathic fibrosis. In the study, the group treated with cycloastragalus alcohol significantly inhibited the progression of pulmonary fibrosis through telomerase activation and reduced the accumulation of senescent cells in the lungs. Studies on the therapeutic effect of cycloastragalus alcohol on small airway epithelial cells or pulmonary fibrosis in vitro showed that telomerase activation and replication life extension were achieved only in epithelial cells, suggesting that the protective mechanism of cycloastragalus alcohol against lung injury involves specific types of lung cells. Therefore, telomerase activators have the potential to treat idiopathic pulmonary fibrosis.
● Antidepressant effect.
In recent years, some scholars have proposed that chronic stress, depression, schizophrenia, and other diseases can be judged by observing the telomere length of peripheral blood lymphocytes. Thus, delaying telomere shortening or even prolonging telomeres can theoretically play a role in the prevention or even treatment of the above diseases. Ip et al. showed that cycloastragalus alcohol could activate telomerase activity and promote the proliferation of neonatal keratinocytes, especially in the healing of keratinocyte wounds in vitro. Meanwhile, cycloastragalus alcohol can induce the activation of telomerase activity and cAMP response element-binding protein (CREB) in PC12 cells and primary neurons. After oral administration of cycloastragalus alcohol for 7 days, the results showed that it could effectively relieve depressive behavior in experimental rats, suggesting that cycloastragalus alcohol has great potential in the development of depression treatment.
● Anti~hyperlipidemia effect.
With the deepening research on the relationship between hyperlipidemia and cardiovascular diseases, the research and development of lipid-lowering drugs have become the focus of competition among major companies. 3T3-L1 pre-adipocytes are often used for screening active ingredients to alleviate obesity. Wang et al., using this cell line as the research platform, showed that cycloastragalus alcohol stimulated calcium influx into 3T3-L1 pre-adipocytes in a dose-dependent trend, with the half-effective concentration reaching 21.9 μmol·L. Literature has shown that increased intracellular calcium plays an important role in inhibiting adipocyte differentiation, so 98% Cycloastragenol Powder alcohol can inhibit the accumulation of cytoplasmic lipid droplets in 3T3-L1 adipocytes, indicating its potential therapeutic effect in reducing obesity and hyperlipidemia.
In addition, Yung et al. studied the mechanism of action of astragaloside IV and cycloastragalus alcohol on the proliferation of CD and T lymphocytes, and the results showed that the two compounds could also stimulate the phosphorylation of extracellular signal-regulated kinases in other cell lines, such as lung, brain, mammary gland, endothelial cells, and hematopoietic organs, thus affecting cell proliferation and differentiation.
Test Method
Chromatographic conditions: Chromatographic column: ZORBAX RX-C18 (4.6mm×150mm), 5μm; Mobile phase: acetonitrile-water (30:70); Flow rate: 1.0mL/min; Column temperature: 35℃; ELSD parameters: Drift tube temperature: 105℃, Nitrogen flow rate: 2.70mL/min.

Prospects
Although 98% cycloastragenol powder has a long history of use, there are very few reports about aglycones - cycloastragalus alcohols of most astragalus saponins. It can be seen from the above literature review that the most effective method for the preparation of cycloastragalus alcohol is the Smith degradation method at present. However, this method has many steps, low yield, and high economic cost, so it still needs further optimization. In particular, cycloastragalus alcohol is easily converted into astragalus alcohol in an acidic environment, which increases the difficulty of preparation.
In addition to the reported anti-aging, antiviral, lung injury protection, antidepressant, anti-hyperlipidemia, and other activities, further studies are needed to prepare drugs and apply them into practice. Additionally, the structural analogs of cycloastragalus alcohol obtained through hydrolysis and biocatalysis may also have certain biological activity, which is also a direction for future research. It can be seen that cycloastragalus alcohol has broad research space and good market development prospects.
Factory&Team:

Certification

Package & Shipment

Hot Tags: 98% cycloastragenol powder, China 98% cycloastragenol powder manufacturers, suppliers, factory, Gynostemma Extract Powder, Garcinia Extract Powder, Rice Bran Extract, Sodium Copper Chlorophyllin Powder, bulk fisetin, Chicory Inulin Powder
You Might Also Like











